These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Nicorandil: do the dermatological and gastrointestinal risks outweigh the benefits? Smith VM; Lyon CC Br J Dermatol; 2012 Nov; 167(5):1048-52. PubMed ID: 23039135 [TBL] [Abstract][Full Text] [Related]
16. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects. Markham A; Plosker GL; Goa KL Drugs; 2000 Oct; 60(4):955-74. PubMed ID: 11085202 [TBL] [Abstract][Full Text] [Related]
17. Nicorandil: more cases of mucocutaneous ulceration. Prescrire Int; 2012 Nov; 21(132):267. PubMed ID: 23210258 [TBL] [Abstract][Full Text] [Related]
18. Nicorandil-induced leg ulceration without mucosal involvement. Mikeljevic J; Highet AS Clin Exp Dermatol; 2011 Jun; 36(4):372-3. PubMed ID: 21564175 [TBL] [Abstract][Full Text] [Related]
20. Risk of skin ulcerations associated with oral nicorandil therapy: a population-based study. Lee MT; Lin HY; Lee SH; Lee SH; Chang SS; Chen SC; Lee CC Br J Dermatol; 2015 Aug; 173(2):498-509. PubMed ID: 25939634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]